T-cell immunotherapies (TCI) are redefining cancer care, with chimeric antigen receptor T-cell (CAR-T) therapies witnessing ...

The introduction of outpatient flat-rate payments approved today by the Swiss Federal Council poses significant risks for ...

In the USA, the Trump administration is urging congressional Republicans to include a “most favored nation” (MFN) policy in ...

Sweden’s Mendus (STO: IMMU), a clinical-stage drug developer, has announced the appointment of Dr Tariq Mughal as chief ...

US biotech Biohaven last week received a commitment from Oberland Capital to invest up to $600 million in the company. Also, ...

The US Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) have announced a $500 ...

Danish allergy immunotherapy specialist ALK Abello (OMX: ALK B) has announced a four-year agreement with USA-based ARS ...

US biotech Jazz Pharmaceuticals (Nasdaq: JAZZ) is banking on continued growth from Epidiolex (cannabidiol), the first ...

The global dermatological cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth ...

The pharmaceutical industry in Latin America is currently facing several challenges in terms of containment of chronic ...

Mergers and acquisitions (M&As) in the biopharmaceutical industry surged 101% in total deal value in first-quarter 2025 from ...

The head of the World Health Organization has issued a stark warning that sudden cuts to global health budgets, including by ...